Showing results (21-30 of 43) with videos related to
Sort By:
Pageof 5
International Journal of Molecular Sciences|October 16, 2024
B-Cell Maturation Antigen (BCMA) as a Biomarker and Potential Treatment Target in Systemic Lupus ErythematosusJonas Martin, Qingyu Cheng, Sarah A Laurent, et al.International Journal of Molecular Sciences|March 28, 2026
Increased Type I Interferon Activity with Concurrent Plasmablast Expansion Identifies Systemic Lupus Erythematosus Patients with Poor OutcomesKonrad Speidel, Qingyu Cheng, Laleh Khodadadi, et al.European Journal of Immunology|July 7, 2018
Proteasome inhibition with bortezomib induces a therapeutically relevant depletion of plasma cells in SLE but does not target their precursorsTobias Alexander, Qingyu Cheng, Jens Klotsche, et al.Journal of Neuroinflammation|February 10, 2026
GPR35 protects against reperfusion injury in ischemic stroke by binding with the CR2 domain of Raf1Xiaojun Li, Qi Wang, Qingyu Cheng, et al.European Journal of Immunology|November 13, 2019
Selective depletion of plasma cells in vivo based on the specificity of their secreted antibodiesQingyu Cheng, Andreas Pelz, Adriano Taddeo, et al.Arthritis Research & Therapy|April 19, 2015
Long-lived plasma cells are early and constantly generated in New Zealand Black/New Zealand White F1 mice and their therapeutic depletion requires a combined targeting of autoreactive plasma cells and their precursorsAdriano Taddeo, Laleh Khodadadi, Caroline Voigt, et al.Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|December 26, 2023
IL-4-secreting CD40L<sup>+</sup> MAIT cells support antibody production in the peripheral blood of Heonch-Schönlein purpura patientsMuziying Liu, Ziqiang Yang, Qielan Wu, et al.Oxidative Medicine and Cellular Longevity|January 24, 2022
LYAR Promotes Colorectal Cancer Progression by Upregulating <i>FSCN1</i> Expression and Fatty Acid MetabolismYupeng Wu, Yu Zhou, Haiying Gao, et al.International Journal of Biological Sciences|March 9, 2026
ANXA1-mediated mTOR/FABP4 Inhibition Drives Antifibrotic Macrophage Reprogramming in Lupus NephritisJuan Tao, Qingyu Cheng, Pinjie Zhang, et al.Cell Research|July 29, 2022
Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including OmicronHuan Ma, Xinghai Zhang, Peiyi Zheng, et al.Pageof 5